REFERENCES
- Bamashmus M A, Matlhaga B, Dutton G N. Causes of blindness and visual impairment in the West of Scotland. Eye 2004; 18: 257–261
- Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology 1978; 85: 82–106
- Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991; 98: 766–785
- Olson J A, Strachan F M, Hipwell J H, Goatman K A, McHardy K C, Forrester J V, et al. A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy. Diabet Med. 2003; 20: 528–534
- Leese G P, Morris A D, Olson J. A national retinal screening programmed for diabetes in Scotland. Diabet Med. 2003; 20: 962–964
- Rhatigan M C, Leese G P, Ellis J, Ellingford A, Morris A D, Newton R W, et al. Blindness in patients with diabetes who have been screened for eye disease. Eye 1999; 13: 166–169
- McCarty C A, Lloyd-Smith C W, Lee S E, Livingston P M, Stanislavsky Y L, Taylor H R. Use of eye care services by people with diabetes: The Melbourne Visual Impairment Project. Br J Ophthalmol 1998; 82: 410–414
- Kaur H, Maberley D, Chang A, Hay D. The current status of diabetes care, diabetic retinopathy screening and eye-care in British Columbia's First Nations Communities. Int J Circumpolar Health 2004; 63: 277–285
- Moss S E, Klein R, Klein B E. Factors associated with having eye examinations in persons with diabetes. Arch Fam Med. 1995; 4: 529–534
- Roy M S. Eye care in African Americans with type 1 diabetes: The New Jersey 725. Ophthalmology 2004; 111: 914–920
- Hartnett M E, Key I J, Loyacano N M, Horswell R L, Desalvo K B. Perceived barriers to diabetic eye care: qualitative study of patients and physicians. Arch Ophthalmol 2005; 123: 387–391
- Lawton J, Parry O, Peel E, Douglas M. Diabetes service provision: A qualitative study of newly diagnosed Type 2 diabetes patients' experiences and views. Diabet Med. 2005; 22: 1246–1251
- Peel E, Parry O, Douglas M, Lawton J. Diagnosis of type 2 diabetes: a qualitative analysis of patients' emotional reactions and views about information provision. Patient Educ Couns. 2004; 53: 269–275
- Murthy G V, Gupta S K. Qualitative research in ophthalmic sciences. Indian J Ophthalmol 1999; 47: 257–264
- Walker E A, Basch C E, Howard C J, Zybert P A, Kromholz W N, Shamoon H. Incentives and barriers to retinopathy screening among African-Americans with diabetes. J. Diabet Complicat. 1997; 11: 298–306
- Pasagian-Macaulay A, Basch C E, Zybert P, Wylie-Rosett J. Ophthalmic knowledge and beliefs among women with diabetes. Diabet Educ. 1997; 23: 433–437
- Lee S J, Sicari C, Harper C A, Livingston P M, McCarty C A, Taylor H R, et al. Examination compliance and screening for diabetic retinopathy: A 2-year follow-up study. Cli. Experiment Ophthalmol 2000; 28: 149–152
- Halbert R J, Leung K M, Nichol J M, Legorreta A P. Effect of multiple patient reminders in improving diabetic retinopathy screening. A randomized trial. Diabet Care 1999; 22: 752–755
- Trento M, Bajardi M, Borgo E, Passera P, Maurino M, Gibbins R, et al. Perceptions of diabetic retinopathy and screening procedures among diabetic people. Diabet Med 2002; 19: 810–813
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317: 703–713
- UKPDS. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837–853
- Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. Ophthalmology 1995; 102: 647–661